These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 26848980)
21. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2. Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer. Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2. Yang A; Wang H; Yang X Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366 [TBL] [Abstract][Full Text] [Related]
24. Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma. Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu Q; Tan JH; Wu DM; Lu J; Zheng YL J Cell Biochem; 2018 Feb; 119(2):1827-1840. PubMed ID: 28796375 [TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. Li X; Lin Y; Yang X; Wu X; He X Biochem Biophys Res Commun; 2016 May; 473(4):913-919. PubMed ID: 27040767 [TBL] [Abstract][Full Text] [Related]
26. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008 [TBL] [Abstract][Full Text] [Related]
27. EZH2 Mediates the Regulation of S100A4 on E-cadherin Expression and the Proliferation, Migration of Gastric Cancer Cells. Liu S; Chen D; Shen W; Chen L; Yu A; Fu H; Sun K; Sun X Hepatogastroenterology; 2015 May; 62(139):737-41. PubMed ID: 26897964 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740 [TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2. Chen XJ; An N J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896 [TBL] [Abstract][Full Text] [Related]
30. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935 [TBL] [Abstract][Full Text] [Related]
31. LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2. Zhang C; Shao S; Zhang Y; Wang L; Liu J; Fang F; Li P; Wang B Life Sci; 2020 Feb; 243():117295. PubMed ID: 31927050 [TBL] [Abstract][Full Text] [Related]
32. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer. Ding M; Zhang H; Li Z; Wang C; Chen J; Shi L; Xu D; Gao Y Clin Exp Pharmacol Physiol; 2015 May; 42(5):458-64. PubMed ID: 25739318 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Luo M; Li Z; Wang W; Zeng Y; Liu Z; Qiu J Cancer Lett; 2013 Jun; 333(2):213-21. PubMed ID: 23354591 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. Cai Q; Jin L; Wang S; Zhou D; Wang J; Tang Z; Quan Z Oncotarget; 2017 Jul; 8(29):47957-47968. PubMed ID: 28624787 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines. Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601 [TBL] [Abstract][Full Text] [Related]
36. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3. Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307 [TBL] [Abstract][Full Text] [Related]
37. Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. Toll AD; Dasgupta A; Potoczek M; Yeo CJ; Kleer CG; Brody JR; Witkiewicz AK Hum Pathol; 2010 Sep; 41(9):1205-9. PubMed ID: 20573371 [TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells. Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932 [TBL] [Abstract][Full Text] [Related]
39. Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma. Zeng J; Xiang W; Zhang Y; Huang C; Chen K; Chen Z BMC Cancer; 2019 Sep; 19(1):874. PubMed ID: 31481081 [TBL] [Abstract][Full Text] [Related]
40. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2. Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]